Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

The outbreak of SARS-CoV-2 developed into a global pandemic affecting millions of people worldwide. Despite one year of intensive research, the current treatment options for SARS-CoV-2 infected people are still limited. Clearly, novel antiviral compounds for the treatment of SARS-CoV-2 infected pati...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Sand, Lukas, Bormann, Maren, Alt, Mira, Schipper, Leonie, Heilingloh, Christiane Silke, Steinmann, Eike, Todt, Daniel, Dittmer, Ulf, Elsner, Carina, Witzke, Oliver, Krawczyk, Adalbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066091/
https://www.ncbi.nlm.nih.gov/pubmed/33918301
http://dx.doi.org/10.3390/v13040609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066091/
https://www.ncbi.nlm.nih.gov/pubmed/33918301
http://dx.doi.org/10.3390/v13040609

Ejemplares similares